Munich, Germany

Eveline Schaadt


 

 

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • München, DE (2012)
  • Oberhaching, DE (2021 - 2022)
  • Munich, DE (2016 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: The Innovative Contributions of Eveline Schaadt

Introduction

Eveline Schaadt is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. With a total of eight patents to her name, her work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Among her latest patents is the development of Anti-BAFFR antibody formulations and methods of use thereof. These antibodies are formulated as either lyophilisates or liquid formulations. The lyophilisates can be reconstituted to create a solution with a high concentration of the antibody active ingredient, allowing for effective delivery to patients without high levels of antibody aggregation. The aqueous pharmaceutical composition may include various components such as sugars, buffering agents, surfactants, and free amino acids. Another notable patent involves TREM2 stabilizing antibodies, which bind to and stabilize the human Triggering Receptor Expressed on Myeloid cells 2 (TREM2) protein, providing methods for their use in therapeutic applications.

Career Highlights

Eveline has worked with leading companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma AG. Her experience in these organizations has allowed her to refine her expertise in antibody development and formulation.

Collaborations

Throughout her career, Eveline has collaborated with talented professionals, including

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…